SUMMARY Vascular anomalies of the gastrointestinal tract are an important source of both acute and chronic blood loss. They present difficult management problems as they are often multiple, involving more than one part of the gastrointestinal tract, and may give rise to bleeds of increasing frequency and severity over a period of many years. We present the results of endoscopic argon and Nd YAG laser treatment of 18 patients with documented recurrent, severe haemorrhage from vascular lesions of the upper gastrointestinal tract with follow up of up to five years. Four patients with hereditary haemorrhagic telangiectasia, five with single angiodysplasias and three with multiple angiodysplasias have had their transfusion requirements reduced to minimal levels after one or more courses of laser treatment. Two of these have required no blood for over two years despite previous total requirements of 52 and 129 units of blood. Four patients were submitted to surgery (two in whom the laser failed to control haemorrhage and two who did not have immediate access to laser therapy at the time of severe bleed). Two of these, however, bled again soon afterwards. Two patients are still undergoing courses of laser therapy although have already shown reductions in transfusion requirements. Both lasers were effective. The Nd YAG laser appears to produce better long term results as its greater penetration makes it possible to ablate the main areas of vascular ectasia in the submucosa, although it does have a slightly higher risk of causing haemorrhage in the first few days after treatment.
Vascular anomalies of the upper and lower gastrointestinal tract can cause acute and chronic blood loss and although relatively rare, are being recognised with increasing frequency both at endoscopy and angiography. They may be responsible for up to 3% of upper gastrointestinal bleeds' and as many as 35% of severe acute lower gastrointestinal bleeds.2 A range of non-neoplastic vascular anomalies occur in the gastrointestinal tract. The most specific lesions are those of hereditary haemorrhagic telangiectasia or Osler-Weber-Rendu Syndrome. About 13% of patients with haemorrhagic telangiectasia have significant gastrointestinal haemorrhage.3
Single or multiple lesions without the associated features of haemorrhagic telangiectasia are more likely to be degenerative in nature and are referred to in this report as angiodysplasias. 4 These have been associated with valvular heart disease (particu-Those in the caecum have been thought to be produced by chronic, intermittent low-grade obstruction of submucosal veins. 4 In both haemorrhagic telangiectasia and angiodysplasia, the essential features are fragile leashes of thin walled blood vessels in the submucosa which may break through the mucosa (perhaps by minor local trauma or increased venous pressure) and cause significant blood loss into the lumen of the gut.4 7 In this report, we analyse 18 cases referred for laser treatment for whom we have precise details of recurrent haemorrhage of varying severity prior to referral and follow up for periods up to five years.
Methods

PATIENTS
All patients were referred to University College Hospital for laser treatment with a firm or provisional diagnosis of haemorrhage from vascular lesions of the upper gastrointestinal tract. The diagnosis was confirmed at endoscopy carried out under sedation with diazepam and performed with care to minimise local trauma from the instrument (particularly from suction artefacts). Gastric secretions and any old or fresh blood were cleared from suspicious areas by gentle washing. A positive diagnosis was based on the identification of one or more bright red lesions on the mucosa (occasionally associated with small areas of superficial ulceration). These were raised (umbilicated), flat or depressed, but all lesions in any one patient were similar. Lesions seen to bleed spontaneously or which oozed on gentle washing or on treatment were thought most likely to be sites of significant blood loss. They varied in size from 1 cm diameter to less than 1 mm across, the latter only being distinguished from innocent red spots by the observation of bleeding. All but one had sharply defined margins and most were roughly oval in shape. (It should be noted that occasional large raised vascular lesions can be cavernous and deep and are not suitable for laser therapy). Patients with typical mucocutaneous lesions and a positive family history were considered as haemorrhagic telangiectasia (although one patient (case 7) without a family history was included as she had typical mucocutaneous lesions and multiple arteriovenous malformations, particularly in the liver and pancreas).3 Patients without these features were considered as angiodysplasias. All were given blood transfusions and iron supplements as required to maintain an adequate haemoglobin.
Initially, in 1979, only an argon ion laser was available (Model 770, Spectra Physics Ltd, St Albans). This was used at a power of 5-6 w with pulses of 1-3 seconds duration to ablate the mucosal lesion as seen endoscopically -that is, to blanch or destroy the red areas of vascular ectasia. This usually created a shallow ulcer and care was taken to limit the total energy deposited on any one spot to below 50 J (the safe limit established in animal experiments to avoid perforation).17 Some oozing was usually seen during treatment but this always ceased spontaneously. After laser treatment, full doses of cimetidine or ranitidine were prescribed for one month to hasten healing of the iatrogenic ulcers.
In 1981, a Nd YAG laser became available (Fiberlase 100, Barr & Stroud Ltd, Glasgow) and since this time, all endoscopic treatment for this kind of lesion has been carried out with this instrument. As with the argon laser, the total energy on any one spot in one treatment session was limited to the safe limit established in animal experiments (600 J for this laser)18 using shots of 60-70 w for 0 5 seconds. The immediate visual effect was, however, often different as the first change was blanching, to be followed a few days later by superficial ulceration rather than the immediate loss of superficial cells often seen with the argon laser. Both lasers caused superficial charring if fired at fresh blood. With both lasers, if the safe limit of energy dissipation was reached on any lesion without adequate visual effect, treatment on that spot was stopped, to be continued after a time interval of at least two weeks when the treated area would have had sufficient opportunity to heal to make further treatment safe. In all cases of haemorrhagic telangiectasia, there were too many lesions to treat in one session, but endoscopy could be repeated every few days, as different lesions were treated on each occasion. All patients had repeated endoscopies until it was judged that the vascular anomalies as visualised endoscopically had been ablated. If blood loss could not be adequately controlled endoscopically, surgery was carried out to resect the area containing the most significant lesions. Long term follow up was carried out at the referring hospitals and the patient seen again by us if further bleeding occurred. Blood transfusion requirements were documented as precisely as possible from the first evidence of gastrointestinal blood loss to the present time.
Results
Eighteen patients have been treated, eight with hereditary haemorrhagic telangiectasia and 10 with angiodysplasia (single and multiple lesions). All had required blood transfusion for acute blood loss before referral and eight had developed major problems in cross matching in view of the large numbers of transfusions they had received. Five had required previous surgical intervention for gastrointestinal blood loss. Two had segmental jejunal resections, one had a vagotomy and pyloroplasty and one a hemicolectomy. The fifth had a partial gastrectomy, a hemicolectomy and a segmental jejunal resection. Of all these seven procedures, only one of the jejunal resections and the partial gastrectomy had any definite benefit on reducing the blood loss. One patient had had previous successful embolisation of an arteriovenous malformation of the pancreas. Five patients also had lesions of the mitral or aortic valves and one was on chronic haemodialysis.
Details of the patients are shown in Table 1 and the results of treatment in Tables 2 and 3 . The pattern of blood loss in the two groups was different. The patients with haemorrhagic telangiectasia had longer histories of blood loss with less severe acute episodes, although all had increasing loss in the period leading up to their referral. To provide a comparison between patients in this group, the pretreatment requirements in Table 2 are given as the average monthly requirements for the three month periods up to and including initial or subsequent courses of treatment. Most of the patients with angiodysplasia had shorter histories (less than a year) of recurrent episodes of bleeding leading to their referral to us. The duration of this period varied from one to 24 months and the pretreatment transfusion column in Table 3 shows the average monthly requirements during this period. In cases in which major haemorrhage recurred, the period leading up to the second referral is shown as a second line in the pretreatment column. Figure 1 shows the pattern of blood loss in relation to the therapeutic manoeuvres applied for three illustrative cases. The number of laser endoscopies required to complete courses of therapy is shown in Table 4 . The large number of sessions required to complete the initial course of treatment for patients 1 and 2 (11 and nine endoscopies respectively) reflects both our caution with a new technique and the large number of lesions present in each of these ladies. The multiple sessions required to treat single large angiodysplasias reflect the need to limit the energy dissipated on one spot at one time. The results for each course of therapy are shown in Table  5 and the current situation for each patient in Table  6 .
There were no perforations. The only complication that might be attributable to the laser treatment was exacerbation of the bleeding. bleeding point in one of the treated lesions. Detailed studies were possible on two of the three specimens available following resection of gastric lesions previously treated endoscopically. Figure 2 shows an angiogram of the resected stomach in case 1, which reveals discrete areas of vascular ectasia. Only the argon laser was used in this case. A section through a treated lesion is shown in Fig. 3 . Figure 4 illustrates a section taken adjacent to a treated telangiectasia. Only a small sleeve resection was made in case 7 and we were unable to identify the precise bleeding point in the specimen. Figure 5 , however, shows a section through the treated area (only the Nd YAG laser was used in this case). Quantitative measurements showed the zone of with haemorrhagic telangiectasia). 10 Single angiodysplasias can be treated successfully by surgery if their location can be identified precisely by angiography or endoscopy.9 20 Likewise, the five cases with single upper gastrointestinal tract lesions that we have treated endoscopically have done well, only one requiring a second course of treatment, which was successful. The distribution of multiple lesions often makes complete resection impossible, particularly as new lesions tend to form later in other areas.3 Two of our four cases that came to surgery bled again later. Case 1 required a revision gastrectomy 16 months after the first operation. Case 17 bled again from the gastric remnant within a month of his subtotal gastrectomy, but was then successfully treated with the Nd YAG laser. In retrospect, both these patients might not have rebled if their initial operation had been a total gastrectomy, but even now, both are potentially at risk from haemorrhage from other parts of the GI tract. In many cases, the physician is also faced with the difficult task of deciding whether a particular lesion is a significant source of blood loss. In four of our patients (cases 7, 11, 14, and 18) lesions were positively identified by angiography or endoscopy in difficult to decide whether the patient was bleeding from the iatrogenic ulcer or from the original vascular malformation. No perforations occurred, however, and three out of four patients benefited (one requiring multiple coagulations). Jensen has had encouraging results with the heater probe and bicap probe in 26 patients. 13 Another technique that has been reported recently is endoscopic sclerotherapy.12 One half to 1 millilitre of sodium morrhuate was injected submucosally, and this stopped all bleeding from three patients with haemorrhagic telangiectasia (follow up six to 12 months). This approach is simple and inexpensive, but needs fuller assessment.
Problems of electrode tissue adherence and difficulty predicting the extent of tissue damage produced by diathermy led to a search for alternative no-touch techniques. The argon and Nd YAG lasers seemed the most promising of these. The laser energy is delivered via a flexible fibre passed through the biopsy channel of the endoscope and held above the target area without touching it. Experimental studies show that the extent of damage is more predictable than with diathermy and depends on the energy dissipated.'7 21 22 Encouraging results with the argon laser have been reported. Waitman et al had complete cessation of bleeding in 66% of 50 patients with six months to four years follow up.' 1In 30 patients, Jensen et al showed a significant reduction in emergency admissions for haemorrhage, total transfusions and surgery.'3 Our own early results with this laser were promising. When our first case required an emergency gastrectomy and we had the opportunity to study the effects of our treatment on the resected specimen, however, it became apparent that the argon laser was only treating the tip of the iceberg. Even though a small ulcer had been deliberately created at endoscopy, the extensive submucosal vascular malformation had hardly been touched, either immediately below the treated area or more laterally under normal mucosa (Figs 3 and 4) . This would make it more likely that the bleeding could recur later if further vascular ectasias formed in the mucosa which could link the persisting submucosal vascular lake with the lumen of the intestine. It was for this reason that we changed to the Nd YAG laser which can coagulate through a greater depth of tissue. Case 7 gave us an opportunity to study the effects after treatment with the Nd YAG laser (Fig. 5) and from the measurements on these sections (given above) it is apparent that the zone of inflammation and fibrosis is three to four times thicker than with the argon laser. This zone represents the region where one can hope to ablate the vascular ectasia and replace it with fibrosis and as its thickness is 
